These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21448138)

  • 1. Heart failure: pentraxin 3—a marker of diastolic dysfunction and HF?
    Kaess BM; Vasan RS
    Nat Rev Cardiol; 2011 May; 8(5):246-8. PubMed ID: 21448138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Sugamura K; Konishi M; Ohba K; Matsuzawa Y; Akiyama E; Yamamoto E; Sakamoto K; Nagayoshi Y; Kaikita K; Sumida H; Kim-Mitsuyama S; Ogawa H
    J Am Coll Cardiol; 2011 Feb; 57(7):861-9. PubMed ID: 21310324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.
    Gohar A; Kievit RF; Valstar GB; Hoes AW; Van Riet EE; van Mourik Y; Bertens LC; Boonman-Winter LJ; Bots ML; Den Ruijter HM; Rutten FH
    Eur J Prev Cardiol; 2019 Apr; 26(6):613-623. PubMed ID: 30482050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling.
    Motiwala SR; Szymonifka J; Belcher A; Weiner RB; Baggish AL; Gaggin HK; Bhardwaj A; Januzzi JL
    J Cardiovasc Transl Res; 2014 Mar; 7(2):250-61. PubMed ID: 24309956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
    Abernethy A; Raza S; Sun JL; Anstrom KJ; Tracy R; Steiner J; VanBuren P; LeWinter MM
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29650706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.
    Zile MR; Baicu CF
    J Cardiovasc Transl Res; 2013 Aug; 6(4):501-15. PubMed ID: 23716130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Phenogroups in patients with subclinical diastolic dysfunction using unsupervised statistical learning.
    Kaptein YE; Karagodin I; Zuo H; Lu Y; Zhang J; Kaptein JS; Strande JL
    BMC Cardiovasc Disord; 2020 Aug; 20(1):367. PubMed ID: 32795252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3.
    Ishino M; Takeishi Y; Niizeki T; Watanabe T; Nitobe J; Miyamoto T; Miyashita T; Kitahara T; Suzuki S; Sasaki T; Bilim O; Kubota I
    Circ J; 2008 Nov; 72(11):1800-5. PubMed ID: 18832778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of diastolic heart failure.
    Fukuta H; Little WC
    Curr Cardiol Rep; 2007 May; 9(3):224-8. PubMed ID: 17470335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study.
    Lin YT; Lin YH; Wu XM; Ko CL; Yen RF; Chen YH; Hsu RB; Lee CM; Wang SS; Chen MF; Wu YW
    Oncotarget; 2017 Jan; 8(2):2381-2390. PubMed ID: 27924061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of C-reactive protein for the prediction of post-infarct left ventricular systolic dysfunction and heart failure.
    Swiatkiewicz I; Taub PR
    Kardiol Pol; 2018; 76(5):821-829. PubMed ID: 29633232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diastolic dysfunction and diastolic heart failure].
    Rossi G
    Recenti Prog Med; 2007; 98(7-8):407-16. PubMed ID: 17685191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
    Pellicori P; Zhang J; Cuthbert J; Urbinati A; Shah P; Kazmi S; Clark AL; Cleland JGF
    Cardiovasc Res; 2020 Jan; 116(1):91-100. PubMed ID: 31350553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-pro-BNP during isotonic and isometric exercise in heart failure patients with preserved LV ejection fraction.
    Zdrenghea DT; Ilea M; Bodizs G; Sitar-Tăut A; Zdrenghea M; Pop D
    Clin Lab; 2014; 60(12):2055-61. PubMed ID: 25651741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative.
    Ferreira JP; Girerd N; Duarte K; Coiro S; McMurray JJ; Dargie HJ; Pitt B; Dickstein K; Testani JM; Zannad F; Rossignol P;
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28159825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
    Bolat I; Biteker M
    Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.